Home › Acoustic Neuroma › NCT05622344
StableEyes With Active Neurofeedback
RecruitingHealthy volunteers welcome
StableEyes With Active Neurophysiological Feedback
Who can join
Ages 21 to 70 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: 1. Provision of signed and dated informed consent form 2. Stated willingness to comply with all study procedures and availability for the duration of the study 3. In good general health as evidenced by medical history or diagnosed with unilateral vestibular schwannoma 4. Willing to adhere to the SWAN and/or vestibular rehabilitation regimen Exclusion Criteria: 1. Current use of anti-nausea medication 2. Presence of cervical spine pathology that limits head motion to \< 30 degrees in the horizontal or vertical plane (i.e. degenerative disc disease, rheumatoid arthritis) 3. Any orthopedic pathology that prevents walking or standing independently (i.e. recent surgery) 4. Legal blindness (20/200 or worse visual acuity) 5. Treatment using a motion sickness investigational drug or other motion sickness behavioral intervention within 30 days
About the study
The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.
What is being tested
- Traditional Therapy (behavioral)
- SWAN (device)
Sponsor: Johns Hopkins University · Participants: 48 · Started: Aug 8, 2022
Contact the study team
- Michael Schubert, PhD · Phone: 4108427403
- Matthew Stewart, MD PhD · Phone: 4109553492
Official record on ClinicalTrials.gov — NCT05622344
Locations in the U.S.
| Maryland | Johns Hopkins University, Baltimore |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.